IL82523A - Pharmaceutical composition comprising a surface-active compound and fluorinated compound capable of emitting ionic fluorine for inhibiting or destroying a unicellular living being or virus and inhibiting or destroying an enzyme associated with the being or virus - Google Patents

Pharmaceutical composition comprising a surface-active compound and fluorinated compound capable of emitting ionic fluorine for inhibiting or destroying a unicellular living being or virus and inhibiting or destroying an enzyme associated with the being or virus

Info

Publication number
IL82523A
IL82523A IL82523A IL8252387A IL82523A IL 82523 A IL82523 A IL 82523A IL 82523 A IL82523 A IL 82523A IL 8252387 A IL8252387 A IL 8252387A IL 82523 A IL82523 A IL 82523A
Authority
IL
Israel
Prior art keywords
destroying
inhibiting
virus
living
pharmaceutical composition
Prior art date
Application number
IL82523A
Other versions
IL82523A0 (en
Original Assignee
Atlantic Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8607310A external-priority patent/FR2598916B1/en
Application filed by Atlantic Pharma Prod filed Critical Atlantic Pharma Prod
Publication of IL82523A0 publication Critical patent/IL82523A0/en
Publication of IL82523A publication Critical patent/IL82523A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/10—Fluorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Plant Pathology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Communicable Diseases (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

Pharmaceutical or cosmetic substance or composition inhibiting or destroying at least one monocellular living being and/or at least one virus, medicament or product including such composition, process for producing such composition, chemical compound entering in such composition, and process for the inhibition or destruction of at least one unicellular living being and/or at least one virus. The inhibiting or destroying substance, according to the invention, is characterized in that it comprises at least one basic active principle inhibiting or destroying said unicellular living being and a principle for inhibiting or destroying at least one enzyme associated with said living being, forming an activator - particularly acting by synergy - of the basic active principle.
IL82523A 1986-05-22 1987-05-14 Pharmaceutical composition comprising a surface-active compound and fluorinated compound capable of emitting ionic fluorine for inhibiting or destroying a unicellular living being or virus and inhibiting or destroying an enzyme associated with the being or virus IL82523A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8607310A FR2598916B1 (en) 1986-05-22 1986-05-22 FLUORINATED CHEMICAL COMPOUND USED IN A LOCAL CONTRACEPTION METHOD AND FLUORINATED LOCAL CONTRACEPTIVE COMPOSITION, ESPECIALLY SPERMICIDE
EP86402716A EP0253037B1 (en) 1986-05-22 1986-12-08 Inhibitory composition for at least one monocellular living being and/or virus, manufacturing process and uses of this composition

Publications (2)

Publication Number Publication Date
IL82523A0 IL82523A0 (en) 1987-11-30
IL82523A true IL82523A (en) 1992-05-25

Family

ID=26106166

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82523A IL82523A (en) 1986-05-22 1987-05-14 Pharmaceutical composition comprising a surface-active compound and fluorinated compound capable of emitting ionic fluorine for inhibiting or destroying a unicellular living being or virus and inhibiting or destroying an enzyme associated with the being or virus

Country Status (14)

Country Link
JP (1) JP2559735B2 (en)
CN (1) CN87103752A (en)
AT (1) ATE64854T1 (en)
AU (1) AU7331287A (en)
BR (1) BR8702645A (en)
CA (1) CA1326446C (en)
DK (1) DK173716B1 (en)
FI (1) FI89675C (en)
HU (1) HUT43793A (en)
IE (1) IE60364B1 (en)
IL (1) IL82523A (en)
NO (1) NO872142L (en)
OA (1) OA08799A (en)
WO (1) WO1987007143A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620620B1 (en) * 1987-09-22 1991-04-05 Atlantic Pharma Prod INHIBITOR OR DESTRUCTIVE SUBSTANCE OF AT LEAST ONE SINGLE-CELL LIVING BEING CONTAINING FLUORINE F- AND LITHIUM LI +
ATE78396T1 (en) * 1987-09-23 1992-08-15 Atlantic Pharma Prod COMPOSITION FOR THE INHIBITION OR DESTRUCTION OF AT LEAST ONE UNICELLATED ANIMAL, CONTAINING A QUATERNARY AMMONIUM FLUORIDE AND PROCESS FOR THE MANUFACTURE OF SUCH SALT.
GB8809177D0 (en) * 1988-04-19 1988-05-25 Merrell Doe Pharmaceuticals In Method of preventing aids transmission-resulting from blood transfusions
DE4236090C1 (en) * 1992-10-26 1994-01-05 Asta Medica Arzneimittel Pharmaceutical preparation for fluoride ion supply
US5658946A (en) * 1996-05-29 1997-08-19 The Procter & Gamble Company Methods for the treatment of herpes virus infections
RU2259825C9 (en) 2001-06-18 2006-04-10 БиоДием Лимитед Substances of antimicrobial, antifungoid and antiprotozoan activities
JP4759104B2 (en) * 2005-08-26 2011-08-31 株式会社ユネクス Sensor holding device
JP6204729B2 (en) * 2013-07-10 2017-09-27 花王株式会社 Water-soluble polymer composition
WO2015161860A1 (en) * 2014-04-25 2015-10-29 Frank Flechsig Improved biocide compositions based on calcium fluoride as well as uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH448388A (en) * 1963-12-30 1967-12-15 Ciba Geigy New dentifrice
US3647700A (en) * 1967-08-14 1972-03-07 Commodity Improvements Inc K2zrf6
US3995029A (en) * 1975-01-02 1976-11-30 Geraldine Fay Weisz Methods for the treatment of acne
US3996350A (en) * 1975-01-02 1976-12-07 Geraldine Fay Weisz Methods and compositions for alleviating fungus infections of the skin
US4097590A (en) * 1975-07-24 1978-06-27 Geraldine Fay Weisz Methods and compositions for treatment of bacterial and fungus infections of the skin
SE444112B (en) * 1978-06-15 1986-03-24 Dental Therapeutics Ab DENTINYTOR CLEANER
US4368186A (en) * 1981-05-07 1983-01-11 Syntex (U.S.A.) Inc. Methods and compositions for intravaginal contraception
US4359475A (en) * 1981-12-21 1982-11-16 Syntex (U.S.A.) Inc. Thioketal substituted N-alkyl imidazoles
US4473547A (en) * 1982-11-18 1984-09-25 Johnson & Johnson Products Inc. Anticaries compositions

Also Published As

Publication number Publication date
OA08799A (en) 1989-03-31
FI89675C (en) 1993-11-10
CA1326446C (en) 1994-01-25
JP2559735B2 (en) 1996-12-04
NO872142L (en) 1987-11-23
DK249287D0 (en) 1987-05-14
FI872253A (en) 1987-11-23
CN87103752A (en) 1988-09-21
AU7331287A (en) 1987-11-26
JPS6322023A (en) 1988-01-29
IE871338L (en) 1987-11-22
IE60364B1 (en) 1994-07-13
FI89675B (en) 1993-07-30
BR8702645A (en) 1988-02-23
ATE64854T1 (en) 1991-07-15
HUT43793A (en) 1987-12-28
DK249287A (en) 1987-11-23
FI872253A0 (en) 1987-05-21
WO1987007143A1 (en) 1987-12-03
NO872142D0 (en) 1987-05-21
DK173716B1 (en) 2001-07-23
IL82523A0 (en) 1987-11-30

Similar Documents

Publication Publication Date Title
HUT59005A (en) Process for producing transdermal pharmaceutical preparations containing 2-amino-6-(propyl-amino)-4,5,6,7-tetrahydro-benzothiazole
DK653688A (en) STABILIZED PHARMACEUTICAL ACTIVE COMPOUNDS, PROCEDURES FOR THEIR PREPARATION AND STABLE PHARMACEUTICAL PREPARATIONS
DK471085D0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING SYNTHETIC PHOSPHOLIPIDER AND A PHARMACEUTICAL ACTIVE SUBSTANCE AND THEIR PREPARATION AND USE
PT95343A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING LOW DOSES OF AN ORAL ANTICOAGULANT AGENT, SUCH AS WARFARIN AND A PLATELET INHIBITOR SUCH AS ACETYLSALYL ACID, AS ACTIVE PROPRIETARY INGREDIENTS FOR OTRATING AND / OR PREVENTION OF HEART DISEASES
ES2061772T3 (en) INHALING AEROSOL INCLUDING A RETINOL ESTER AND / OR RETHINIC ACID.
ZA864002B (en) Gamma-ifn as active substance for inhibiting(preventing)degradation processes in bone
IL82523A (en) Pharmaceutical composition comprising a surface-active compound and fluorinated compound capable of emitting ionic fluorine for inhibiting or destroying a unicellular living being or virus and inhibiting or destroying an enzyme associated with the being or virus
BR9913782A (en) Process of preparing a galenic formulation comprising fenofibrate as an active ingredient, galenic formulation, medication and uses of a liquid medium and fenofibrate particles
UA39884C2 (en) CLODRONIC ACID-BASED TABLET, METHOD OF PRODUCTION AND TREATMENT OF OSTEOPOROSIS
ES2041243T3 (en) APPLICATION OF AT LEAST ONE ACTIVE INHIBITOR OR DESTRUCTIVE PRINCIPLE OF AT LEAST ONE LIVING SOLE OR VIRUS.
DE69230491T2 (en) TRANSFORMED CELLS FOR THE PREVENTION OR TREATMENT OF VIRUS-INDUCED DISEASES, PARTICULARLY PATHOGENIC RETROVIRUS
MX9306607A (en) TILIDINE DINDIHYDROGEN-OTORPHOSPHATE, PROCEDURE FOR ITS OBTAINING AND THE PHARMACEUTICAL PREPARATIONS THAT CONTAIN IT.
ES2043351T3 (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF HEPATIC DISEASES.
DE69026511D1 (en) USE OF GIBBERELLINES FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING PROSTATITIS
DE69004425D1 (en) USE OF C-20 TO C-26 ALIPHATIC ALCOHOLS FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING VIRAL INFECTIONS.
ES2194920T3 (en) AGRICULTURAL CHEMICAL PREPARATION AND PROCEDURE FOR ITS PRODUCTION.
DE68900926D1 (en) PHARMACEUTICAL PREPARATION CONTAINING ZIDOVUDINE AND INOSIPLEX, OR INGREDIENTS THEREOF, FOR THE TREATMENT OF AIDS-RELATED SYNDROME.
DK325387A (en) 4-BENZYLOXY-3-PYRROLIN-2-ON-1-YL ACETAMIDE AND ITS PREPARATION AND USE
DE59006307D1 (en) Bath additive and its use.
FR2700268B1 (en) Cosmetic or pharmaceutical composition, especially dermatological, containing an extract of Vismia.
PT85454A (en) USE OF 15-DEOXY SPERGUALINE AS A MEDICINAL PRODUCT
FR2647784B1 (en) COMBINATION OF VITAMIN A WITH PHYSIOLOGICAL DOSE AND DIFFERENT ACTIVE PRINCIPLES HAVING THERAPEUTIC ACTIVITY
ZA824649B (en) New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds
ITSP910003A0 (en) PROCEDURE FOR BIOLOGICAL DEFENSE OF PLANTS AND THEIR PRODUCTS FROM ATTACKS BY MICREOBIC AND MICELLAR ORGANISMS THROUGH EXTRACTION OF ACTIVE INGREDIENTS FROM THE MICROORGANISM OR FUNGUS THEMSELVES
NL177404C (en) 4-ARYL-5-AMINOALKYL-1,3-DIOXOLONES, THEIR PHARMACEUTICALLY SUITABLE SALTS, PROCESS FOR THEIR PREPARATION, AND MEDICINAL PRODUCTS WITH THESE DIOXOLONES OR THEIR SALTS AS THE ACTIVE SUBSTANCES THEREIN.

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees